Japan Next Generation Sequencing Market Size, Share and Industry Insights 2026–2034

Japan Next-Generation Sequencing Market Report 2026

Market Size in 2025: USD 1.32 Billion

Market Forecast in 2034: USD 8.02 Billion

Market Growth Rate: 22.18% (2026-2034)

According to the latest report by IMARC Group, titled "Japan Next-Generation Sequencing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034," the Japan next-generation sequencing market size reached USD 1.32 Billion in 2025. Looking forward, the market is expected to reach USD 8.02 Billion by 2034, exhibiting a CAGR of 22.18% during the forecast period from 2026 to 2034.

Request a Free Sample PDF for Detailed Market Insights: https://www.imarcgroup.com/japan-next-generation-sequencing-market/requestsample

Japan Next-Generation Sequencing Industry Trends and Demands in 2026

Japan's next-generation sequencing market experiences explosive growth driven by genomics research expansion, personalized medicine adoption, and diagnostic capability advancement. Whole genome sequencing provides comprehensive genetic information. Targeted resequencing focuses on specific regions. Whole exome sequencing analyzes coding regions. RNA sequencing studies gene expression levels. CHIP sequencing identifies protein-DNA interactions. De novo sequencing assembles new genomes. Methyl sequencing analyzes DNA methylation patterns. Sequencing by synthesis provides high accuracy. Ion semiconductor sequencing enables rapid processing. Single-molecule real-time sequencing offers long reads. Nanopore sequencing provides portable functionality. Instruments enable sequencing capability deployment. Reagents and consumables support ongoing operations. Software and services enable data analysis. Biomarker and cancer applications drive adoption. Drug discovery and personalized medicine expand scope. Genetic screening improves disease prevention. Diagnostics support disease identification. Agriculture and animal research expand applications. Academic institutes lead research advancement. Hospitals and clinics apply clinical diagnostics. Pharmaceutical and biotechnology companies drive innovation. Research infrastructure improvement enables adoption. Cost reduction through technology advancement. Accuracy improvement enables clinical application. Throughput expansion supports research scale.

How AI is Reshaping the Future of the Japan Next-Generation Sequencing Market

Data Analysis and Genetic Interpretation: Artificial intelligence analyzes sequencing data comprehensively. Machine learning algorithms interpret genetic findings. Predictive systems forecast disease risk and treatment probability.

Quality Control and Error Detection: AI-powered systems detect sequencing errors. Machine learning algorithms identify quality issues. Predictive systems forecast data quality and accuracy improvements.

Demand Forecasting and Research Trend Analysis: Artificial intelligence predicts NGS adoption patterns. Machine learning models forecast research trend adoption. Predictive systems support market planning and capacity management.

Japan Next-Generation Sequencing Market Segmentation

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan next-generation sequencing market share. It includes forecasts for the period 2026-2034 and historical data from 2020-2025 for the following segments.

By Sequencing Type:

• Whole Genome Sequencing
• Targeted Resequencing
• Whole Exome Sequencing
• RNA Sequencing
• CHIP Sequencing
• De Novo Sequencing
• Methyl Sequencing
• Others

By Product Type:

• Instruments
• Reagents and Consumables
• Software and Services

By Technology:

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others

By Application:

• Biomarker and Cancer
• Drug Discovery and Personalized Medicine
• Genetic Screening
• Diagnostics
• Agriculture and Animal Research
• Others

By End-User:

• Academic Institutes and Research Centers
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others

Regional Insights

• Kanto Region
• Kansai/Kinki Region
• Central/Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

Competitive Landscape

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Japan next-generation sequencing industry.

Key Players:

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California Inc.
• Oxford Nanopore Technologies Plc
• F. Hoffmann-La Roche Ltd.
• BGI Group
• Qiagen
• Takara Bio Inc.
• Macrogen Inc.

Recent News and Developments in Japan Next-Generation Sequencing Market

February 2026: NGS providers announced development of advanced sequencing platforms.

January 2026: Research institutions accelerated NGS adoption supporting research expansion.

Ongoing: Continuous innovation in next-generation sequencing is driving explosive market growth and genomics advancement.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

Street: 563-13 Kamien

Country: Tokyo Japan

Postal Code: 4380111

Email: sales@imarcgroup.com

Source: IMARC Group